Open access · US-GOV via ClinicalTrials.gov Clinical trial

An Open Label Phase I Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV

Authors not listed

Aktion Bronchialkarzinom e.V. · 2013

Deregulated nutrient-sensing Human Randomized controlled trial

Abstract

To investigate the maximum tolerated dose of BIBF 1120 and safety in escalating doses administered with Vinorelbine i.v. and Carboplatin i.v. in elderly patients with advanced Non-Small Lung Cancer (Stage IV).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-19 MST

Cite this

APA

Anonymous. (2013). An Open Label Phase I Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV. <em>Aktion Bronchialkarzinom e.V.</em>. https://clinicaltrials.gov/study/NCT01683682

Vancouver

Anonymous. An Open Label Phase I Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV. Aktion Bronchialkarzinom e.V.. 2013.

BibTeX

@misc{anon2013AnOpen, title = {An Open Label Phase I Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV}, author = {Anonymous}, journal = {Aktion Bronchialkarzinom e.V.}, year = {2013}, }